dalteparin has been researched along with Esophageal Varices in 6 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "SVT favors the relapse of esophageal varices, but rebleeding can be effectively prevented by standard scheduled band ligations." | 1.38 | Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis. ( Amitrano, L; Guardascione, MA; Lampasi, F; Lanza, AG; Manguso, F; Martino, R; Menchise, A; Scaglione, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Z | 1 |
| Li, S | 1 |
| Zhao, J | 1 |
| Li, J | 1 |
| Gao, Y | 1 |
| Bechmann, LP | 2 |
| Sichau, M | 1 |
| Wichert, M | 2 |
| Gerken, G | 1 |
| Kröger, K | 2 |
| Hilgard, P | 2 |
| Northup, PG | 1 |
| Intagliata, NM | 1 |
| Lisman, T | 1 |
| Porte, RJ | 1 |
| Amitrano, L | 1 |
| Guardascione, MA | 1 |
| Scaglione, M | 1 |
| Menchise, A | 1 |
| Martino, R | 1 |
| Manguso, F | 1 |
| Lanza, AG | 1 |
| Lampasi, F | 1 |
1 trial available for dalteparin and Esophageal Varices
| Article | Year |
|---|---|
Anticoagulation therapy early is safe in portal vein thrombosis patients with acute variceal bleeding: a multi-centric randomized controlled trial.
Topics: Albumins; Anticoagulants; Esophageal and Gastric Varices; Fibrosis; Gastrointestinal Hemorrhage; Hum | 2023 |
5 other studies available for dalteparin and Esophageal Varices
| Article | Year |
|---|---|
Low-molecular-weight heparin in patients with advanced cirrhosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Blood Coagulation; Dru | 2011 |
Anticoagulation in cirrhosis patients: what don't we know?
Topics: Anticoagulants; Antithrombin III; Blood Coagulation; Drug Monitoring; Enoxaparin; Esophageal and Gas | 2011 |
Towards a rational use of low-molecular-weight heparin in patients with cirrhosis.
Topics: Anticoagulants; Blood Coagulation; Enoxaparin; Esophageal and Gastric Varices; Female; Humans; Liver | 2011 |
Dosing and monitoring of low-molecular-weight heparin in cirrhotic patients.
Topics: Anticoagulants; Blood Coagulation; Enoxaparin; Esophageal and Gastric Varices; Female; Humans; Liver | 2011 |
Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis.
Topics: Aged; Anticoagulants; Chi-Square Distribution; Endoscopy, Gastrointestinal; Enoxaparin; Esophageal a | 2012 |